InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Whitescarver David, VP du Développement Corporatif et de la PI. Director active across 1 companies, notably Cardiovascular Systems Inc. In total, 10 disclosures have been recorded. The latest transaction was disclosed on 8 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
05,477 shares0
Common Stock
SEC:0001437749-22-002887·
05,477 shares0
Common Stock
SEC:0001437749-22-002887:0·
€10,190429 shares@ €23.753817.5% of flow
Common Stock
SEC:0000914190-21-000409·
€10,190429 shares@ €23.75388.7% of flow
Common Stock
SEC:0000914190-21-000409:0·
01,015 shares0
Common Stock
SEC:0000914190-21-000304·
01,015 shares0
Common Stock
SEC:0000914190-21-000304:0·
€48,1911,568 shares@ €30.733882.5% of flow
Common Stock
SEC:0000914190-21-000264·
€48,1911,568 shares@ €30.733841.3% of flow
Common Stock
SEC:0000914190-21-000264:0·
03,994 shares0
Common Stock
SEC:0000914190-21-000242·
03,994 shares0
Common Stock
SEC:0000914190-21-000242:0·
10 of 10 declarations
About Whitescarver David
David Whitescarver is the VP of Corp. Dev. and IP at Cardiovascular Systems Inc. He is responsible for the company's business development strategy and intellectual property management. With a strong background in the medical sector, he plays a key role in identifying growth opportunities and protecting innovations. His expertise contributes to the company's competitiveness and sustainability.
